These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11448296)

  • 41. Correlation between qualitative balance indices, dynamic posturography and structural brain imaging in patients with progressive supranuclear palsy and its subtypes.
    Pasha SA; Yadav R; Ganeshan M; Saini J; Gupta A; Sandhya M; Pal PK
    Neurol India; 2016; 64(4):633-9. PubMed ID: 27381106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
    Paviour DC; Price SL; Stevens JM; Lees AJ; Fox NC
    Neurology; 2005 Feb; 64(4):675-9. PubMed ID: 15728291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
    Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
    Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study.
    Hwang M; Yang H; Kim Y; Youn J; Park J; Huh YE; Kim HT; Cho JW
    Neurodegener Dis; 2017; 17(1):31-37. PubMed ID: 27614955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
    Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
    Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson's disease.
    Miyata M; Kakeda S; Yoneda T; Ide S; Okada K; Adachi H; Korogi Y
    Neuroradiology; 2023 Apr; 65(4):719-727. PubMed ID: 36670276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
    Surova Y; Nilsson M; Lätt J; Lampinen B; Lindberg O; Hall S; Widner H; Nilsson C; van Westen D; Hansson O
    Neuroradiology; 2015 Nov; 57(11):1079-91. PubMed ID: 26253801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A
    J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI.
    Blain CR; Barker GJ; Jarosz JM; Coyle NA; Landau S; Brown RG; Chaudhuri KR; Simmons A; Jones DK; Williams SC; Leigh PN
    Neurology; 2006 Dec; 67(12):2199-205. PubMed ID: 17190944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability.
    Rolland Y; Vérin M; Payan CA; Duchesne S; Kraft E; Hauser TK; Jarosz J; Deasy N; Defevbre L; Delmaire C; Dormont D; Ludolph AC; Bensimon G; Leigh PN;
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):1025-32. PubMed ID: 21386111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Highly specific radiographic marker predates clinical diagnosis in progressive supranuclear palsy.
    Owens E; Krecke K; Ahlskog JE; Fealey R; Hassan A; Josephs KA; Klassen B; Matsumoto J; Bower J
    Parkinsonism Relat Disord; 2016 Jul; 28():107-11. PubMed ID: 27160570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral Peduncle Angle: An Objective Criterion for Assessing Progressive Supranuclear Palsy Richardson Syndrome.
    Fatterpekar GM; Dietrich A; Pantano P; Saba L; Knopp EA; Piattella MC; Raz E
    AJR Am J Roentgenol; 2015 Aug; 205(2):386-91. PubMed ID: 26204292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MDS criteria for the diagnosis of progressive supranuclear palsy overemphasize Richardson syndrome.
    Frank A; Peikert K; Linn J; Brandt MD; Hermann A
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1702-1707. PubMed ID: 32735745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity.
    Lipp A; Skowronek C; Fehlner A; Streitberger KJ; Braun J; Sack I
    Eur Radiol; 2018 Aug; 28(8):3347-3354. PubMed ID: 29460073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.